Published • loading... • Updated
EXCLUSIVE: Drug companies choosing not to sell life-saving and life-extending medicines in Canada
Summary by City News
1 Articles
1 Articles
EXCLUSIVE: Drug companies choosing not to sell life-saving and life-extending medicines in Canada
When Ruchi Ambike found out that Novartis got Health Canada approval for Vanrafia she was ecstatic. The drug can possibly slow down the progression of her Immunoglobulin gA nephropathy, (IgAN) and ultimately, end-stage kidney disease. “It’s exciting because we have no IgAN drugs in Canada,” she says from her Mississauga home. IgAN is a rare […]
·Toronto, Canada
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
